Company intelligence / Profile preview

deepeye Medical

Munich, Bavaria, Germanydeepeye-medical.com ↗

Ownership: Private
Development stage: Preclinical

Overview

deepeye’s AI platform has demonstrated improved outcomes in real-world use by tripling visual acuity results compared to standard practice and doubling patient adherence over 24 months. It is already used by major pharma companies and medical associations for research purposes, with plans to expand to direct point-of-care integration soon.

Therapeutic areas: Ophthalmology
Modalities: Device (AI-based software as a medical device for therapy decision support)Non-pharmacological therapy (decision support tool)
Industry: Digital Health Medical Devices

Drug pipeline

1 asset

deepeye TPS

Pre-clinical

Indications: Age-related Macular Degeneration

Partnerships

Novartis (customer/use of data)Bayer (research partner)Roche (research partner)Heidelberg Engineering (integration partner)Topcon Healthcare (integration partner)

Beyond the preview

Go deeper on deepeye Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on deepeye Medical.

Explore the full profile